FDA Approval Decisions Report
October, 2008
| Date: | Oct 01, 2008 |
|---|---|
| Format: | |
| Price: | $125.00 |
Abstract
The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates (Prescription Drug User Fee Act) - expected FDA approval dates for NDA/BLA filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Furthermore, the report also analyzes each drug candidate's likelihood of approval and competitive landscape using 3 criteria derived from Revere's patented classification system: (1) Utilization of a mechanism of action previously approved by the FDA, (2) Facing two or fewer alternative drugs with the same mechanism of action for the same indication, and (3) Would be the first or second FDA approved drug for the company. Original, unbiased, insightful and actionable, the Revere FDA Approval Decision Report is an indispensable tool for successful Biotech/Pharmaceutical investing.
Companies Mentioned in the Report
- Abbott Laboratories (ABT) - Overview - Reports
- AMAG Pharmaceuticals, Inc. (AMAG) - Overview - Reports
- Alpharma Inc. (?200936) - Overview - Reports
- Amylin Pharmaceuticals, Inc. (AMLN) - Overview - Reports
- Barr Pharmaceuticals Inc (?203155) - Overview - Reports
- Cephalon Inc (?204110) - Overview - Reports
- Cypress Bioscience, Inc. (?206025) - Overview - Reports
- Eli Lilly & Co. (LLY) - Overview - Reports
- Enzon Pharmaceuticals, Inc. (ENZN) - Overview - Reports
- Forest Laboratories, Inc. (FRX) - Overview - Reports
- Genentech, Inc. (?248964) - Overview - Reports
- General Electric Co (GE) - Overview - Reports
- Genta Incorporated (GNTA) - Overview - Reports
- Genzyme Corporation (?1098629) - Overview - Reports
- Gilead Sciences, Inc. (GILD) - Overview - Reports
- GlaxoSmithKline plc (ADR) (GSK) - Overview - Reports
- Nektar Therapeutics (NKTR) - Overview - Reports
- Johnson & Johnson (JNJ) - Overview - Reports
- K-V Pharmaceutical Company (KV/B) - Overview - Reports
- Ligand Pharmaceuticals Inc. (LGND) - Overview - Reports
- Medarex inc. (?214788) - Overview - Reports
- Novartis AG (ADR) (NVS) - Overview - Reports
- OSI Pharmaceuticals, Inc. (CH716923BCN8001:MSTAR:US) - Overview - Reports
- Pfizer Inc. (PFE) - Overview - Reports
- Pharmaceutical Product Development Inc (?218819) - Overview - Reports
- Watson Pharmaceuticals, Inc. (WPI) - Overview - Reports
- AstraZeneca plc (ADR) (AZN) - Overview - Reports
- King Pharmaceuticals, Inc. (?212886) - Overview - Reports
- Roche Holding Ltd. (ADR) (RHHBY) - Overview - Reports
- Salix Pharmaceuticals, Ltd. (SLXP) - Overview - Reports
- Pain Therapeutics, Inc. (PTIE) - Overview - Reports
- DURECT Corporation (DRRX) - Overview - Reports
- Cipher Pharmaceuticals Inc (CPHMF) - Overview - Reports
- AMEX International Markets Index ($ADR) - Overview - Reports
- Novadel Pharma Inc (NVDL) - Overview - Reports
- Takeda Yakuhin Kogyo KK (TKPYY) - Overview - Reports
- Somaxon Pharmaceuticals, Inc. (SOMX) - Overview - Reports
- Epix Pharmaceuticals Inc (EPIX) - Overview - Reports
- Targanta Therapeutics Corporation (?492045) - Overview - Reports
More Information:
Learn more about FDA Approval Decisions Report.